Updated Jul 16, 2026
Bispham Barbara Harlin has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $22K.

Barbara Harlin Bispham (appearing in SEC filings as Bispham Barbara Harlin) is associated with Crescent Biopharma, Inc. according to the most recent SEC filing dated 2026-06-23. The remarks in the filing do not disclose a specific title or role for her, and no broader biographical details are provided within the context given. Based on the SEC context alone, she appears to be an individual connected to Crescent Biopharma, Inc. but there is no public information in this context about career history, accomplishments, or other affiliations. If you can share the exact filing (e.g., form type) or provide access to the filing text, I can extract the precise role and tenure.
| Role | See Remarks |
|---|---|
| Notability | 12/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | CBIO | CRESCENT BIOPHARMA, INC. | S — Open-market sale | 1.2K | $17.99 | $22K |
Barbara Harlin Bispham (appearing in SEC filings as Bispham Barbara Harlin) is associated with Crescent Biopharma, Inc. according to the most recent SEC filing dated 2026-06-23. The remarks in the filing do not disclose a specific title or role for her, and no broader biographical details are provided within the context given. Based on the SEC context alone, she appears to be a…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($22K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bispham Barbara Harlin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.